Literature DB >> 28965415

Experimental Design in Clinical 'Omics Biomarker Discovery.

Jenny Forshed1.   

Abstract

This tutorial highlights some issues in the experimental design of clinical 'omics biomarker discovery, how to avoid bias and get as true quantities as possible from biochemical analyses, and how to select samples to improve the chance of answering the clinical question at issue. This includes the importance of defining clinical aim and end point, knowing the variability in the results, randomization of samples, sample size, statistical power, and how to avoid confounding factors by including clinical data in the sample selection, that is, how to avoid unpleasant surprises at the point of statistical analysis. The aim of this Tutorial is to help translational clinical and preclinical biomarker candidate research and to improve the validity and potential of future biomarker candidate findings.

Keywords:  biomarker candidates; biomarker discovery; clinical ‘omics; experimental design; translational research

Mesh:

Substances:

Year:  2017        PMID: 28965415     DOI: 10.1021/acs.jproteome.7b00418

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.

Authors:  Nathan Basisty; Abhijit Kale; Sandip Patel; Judith Campisi; Birgit Schilling
Journal:  Expert Rev Proteomics       Date:  2020-05-19       Impact factor: 3.940

Review 2.  Biomarkers for Parkinson's Disease: How Good Are They?

Authors:  Tianbai Li; Weidong Le
Journal:  Neurosci Bull       Date:  2019-10-23       Impact factor: 5.203

Review 3.  Target Discovery for Drug Development Using Mendelian Randomization.

Authors:  Daniel S Evans
Journal:  Methods Mol Biol       Date:  2022

4.  The viral protein corona directs viral pathogenesis and amyloid aggregation.

Authors:  Kariem Ezzat; Maria Pernemalm; Sandra Pålsson; Thomas C Roberts; Peter Järver; Aleksandra Dondalska; Burcu Bestas; Michal J Sobkowiak; Bettina Levänen; Magnus Sköld; Elizabeth A Thompson; Osama Saher; Otto K Kari; Tatu Lajunen; Eva Sverremark Ekström; Caroline Nilsson; Yevheniia Ishchenko; Tarja Malm; Matthew J A Wood; Ultan F Power; Sergej Masich; Anders Lindén; Johan K Sandberg; Janne Lehtiö; Anna-Lena Spetz; Samir El Andaloussi
Journal:  Nat Commun       Date:  2019-05-27       Impact factor: 14.919

5.  Mapping Metabolite and ICD-10 Associations.

Authors:  Egon Taalberg; Kalle Kilk
Journal:  Metabolites       Date:  2020-05-14

Review 6.  Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation.

Authors:  Zhengtao Liu; Jun Xu; Shuping Que; Lei Geng; Lin Zhou; Adil Mardinoglu; Shusen Zheng
Journal:  J Clin Transl Hepatol       Date:  2022-01-04

Review 7.  Proteomic Discovery and Validation of Novel Fluid Biomarkers for Improved Patient Selection and Prediction of Clinical Outcomes in Alzheimer's Disease Patient Cohorts.

Authors:  Shivangi Awasthi; Daniel S Spellman; Nathan G Hatcher
Journal:  Proteomes       Date:  2022-08-01

Review 8.  Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.

Authors:  Bjoern Titz; Raffaella M Gadaleta; Giuseppe Lo Sasso; Ashraf Elamin; Kim Ekroos; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Int J Mol Sci       Date:  2018-09-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.